Share price held back so deal with NOX could happen with management at the best market price. NOX should have raised capital instead of taking cash because they were desperate for it. Haven’t seen management take this volume of stock on a startup biotech. Tells you what’s to come and how big the drug potential is. NYR true valuation will come
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
0.010(4.55%) |
Mkt cap ! $48.51M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 23.0¢ | 22.5¢ | $35.32K | 155.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 50012 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 106360 | 1 |
View Market Depth
| Last trade - 14.38pm 25/06/2025 (20 minute delay) ? |
| NYR (ASX) Chart |